发明名称 Service induced byproducts for localized drug delivery in orthopaedic implants
摘要 A composite material including ultra-high molecular weight polyethylene in conjunction with a biologically active agent is described. The biologically active agent can be, for example, an anti-osteolytic agent such as a bisphosphonate. The composite material can be utilized in forming implants such as total joint replacement implants. The biologically active agent can be released from the composite material either from the bulk or from wear particles released from the surface of the implant component during use. Upon release, the biologically active agent can carry out the intended function of the agent.
申请公布号 US8858979(B1) 申请公布日期 2014.10.14
申请号 US201213360020 申请日期 2012.01.27
申请人 Clemson University 发明人 DesJardins John D.;LaBerge Martine;Wright-Walker Cassandra
分类号 A61L27/14 主分类号 A61L27/14
代理机构 Dority & Manning, P.A. 代理人 Dority & Manning, P.A.
主权项 1. A joint replacement comprising a component, the component comprising an ultra-high molecular weight polyethylene composite, the ultra-high molecular weight polyethylene composite including a biologically active agent blended with the ultra-high molecular weight polyethylene such that the biologically active agent is distributed homogenously or heterogeneously throughout the component.
地址 Clemson SC US